A Subset of Cutaneous Melanoma Express Oncofetal Cripto-1 Protein: Correlation of Histopathology and Prognosis
Cerrahpaşa Medical Journal · 30.06.2026 · 50 · 1-7
DOI: 10.5152/cjm.2026.26030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cerrahpaşa Medical Journal, online erschienen am 30.06.2026. Verfasst von Ayşe Mine Önenerk Men und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Melanoma has a poor prognosis in advanced stages. The study aimed to investigate the immunohistochemical expression of Cripto-1 (CR-1) and its relationship with clinicopathological parameters in cutaneous melanoma cases.
Methods
Cutaneous melanoma cases diagnosed at Cerrahpaşa Medical Faculty between January 2016 and January 2023 were searched from the digital system. Immunohistochemical CR-1 stain was applied to all cases, and the results were compared with clinicopathological parameters.
Results
A total of 78 cutaneous melanoma cases diagnosed between January 2016 and January 2023 were included in the study. CR-1 expression was observed in melanoma cells in 9% (n = 7) of the cases. Although statistically insignificant, CR-1-positive tumors were mostly located on the intermittently sun-exposed skin (57.1%; n = 4), pT4 (71.4%; n = 5), without regression (71.4%; n = 5), low density of tumor-infiltrating lymphocytes (71.4%; n = 5), and BRAFwt tumors (85.7%; n = 6/7). While the average survival was 16.5 ± 11.6 months in CR-1-positive cases and 39.4 ± 3.9 months in CR-1-negative cases, this result was not found to be statistically significant.
Conclusion
CR-1 is a candidate protein for targeted therapy because it is an oncofetal protein and its expression is shown to be increased in malignancies while its expression is low/absent in normal adult tissues. In this study, CR-1 expression was detected in a small subset of melanoma cases and its expression was not correlated with clinicopathologic parameters. Cite this article as: Önenerk Men AM, Namal AH, Demiröz AS, et al. A subset of cutaneous melanoma express oncofetal cripto-1 protein: correlation of histopathology and prognosis. Cerrahpaşa Med J. 2026, 50, 0030, doi: 10.5152/cjm.2026.26030.
Zitieren
APA
Men, A. M. Ö., Namal, A. H., Demiröz, A. S., Şahin, Z., Wetherilt, C. S., Ülgen, Ö. A., Uzunçakmak, T. K., & Turna, Z. H. (2026). A Subset of Cutaneous Melanoma Express Oncofetal Cripto-1 Protein: Correlation of Histopathology and Prognosis. Cerrahpaşa Medical Journal, 50, 1-7. https://doi.org/10.5152/cjm.2026.26030
Vancouver
Men AMÖ, Namal AH, Demiröz AS, Şahin Z, Wetherilt CS, Ülgen ÖA, et al. A Subset of Cutaneous Melanoma Express Oncofetal Cripto-1 Protein: Correlation of Histopathology and Prognosis. Cerrahpaşa Medical Journal. 2026;50:1-7. doi:10.5152/cjm.2026.26030
BibTeX
@article{Men2026,
author = {Men, Ayşe Mine Önenerk and Namal, Ayşe Hanım and Demiröz, Ahu Senem and Şahin, Zehra and Wetherilt, Ceyda Sönmez and Ülgen, Övgü Aydın and Uzunçakmak, Tuğba Kevser and Turna, Zeynep Hande},
title = {A Subset of Cutaneous Melanoma Express Oncofetal Cripto-1 Protein: Correlation of Histopathology and Prognosis},
journal = {Cerrahpaşa Medical Journal},
year = {2026},
volume = {50},
pages = {1--7},
doi = {10.5152/cjm.2026.26030}
}
EUVIMED